** Shares of telehealth firm Hims and Hers HIMS.N rise 16.1% to $67.94
** Co acquires at-home lab testing service Trybe Labs, which offers at-home blood draws and whole body testing for subscribers
** With at-home lab testing, customers will be able to access more information about their health and providers can recommend high-quality customized treatments - HIMS
** HIMS expects to roll out at-home testing over the next year
** HIMS funded the acquisition through cash on hand
** "All-in, our general view is that we need to hear more. Seeing a category expansion, or in this case service expansion, is not a surprise on the surface" - brokerage Leerink Partners
** Stock has risen 6x in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。